Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,947 | 18,705 | 22,675 | 26,634 | 40,320 |
| Receivables | 19,343 | 17,502 | 15,448 | 12,884 | 12,908 |
| Inventories | 2,477 | 2,201 | 1,404 | 1,060 | 1,125 |
| Other current assets | 898 | 965 | 1,004 | 466 | 546 |
| TOTAL | $46,064 | $40,794 | $42,975 | $44,124 | $57,965 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,197 | 4,082 | 3,428 | 822 | 956 |
| TOTAL | $3,197 | $4,082 | $3,428 | $822 | $956 |
| Total Assets | $49,261 | $44,876 | $46,403 | $44,946 | $58,921 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 248 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,866 | 5,941 | 5,280 | 3,241 | 3,867 |
| Accrued Expenses | 3,701 | 2,225 | 2,843 | 3,428 | 3,313 |
| Other current liabilities | 248 | N/A | 248 | 248 | 248 |
| TOTAL | $9,815 | $8,414 | $8,371 | $6,919 | $7,435 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,106 | 18,093 | 18,080 | 18,067 | 29,773 |
| Other Non-Current Liabilities | 25,832 | 25,832 | 25,832 | 25,832 | 26,884 |
| TOTAL | $43,938 | $43,925 | $43,912 | $43,899 | $56,657 |
| Total Liabilities | $53,753 | $52,339 | $52,283 | $50,818 | $64,092 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,117 | 27,832 | 27,619 | 27,594 | 27,432 |
| Common Shares | 147,652 | 146,165 | 145,979 | 145,608 | 145,438 |
| Retained earnings | -224,636 | -223,998 | -220,846 | -219,681 | -217,696 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $-4,492 | $-7,463 | $-5,880 | $-5,872 | $-5,171 |
| Total Liabilities And Equity | $49,261 | $44,876 | $46,403 | $44,946 | $58,921 |